Fasciolosis overview: Difference between revisions

Jump to navigation Jump to search
Turky Alkathery (talk | contribs)
Created page with "__NOTOC__ {{Fasciolosis}} {{PleaseHelp}} ==References== {{reflist|2}} Category:Helminthiases Category:Veterinary helminthology"
 
Turky Alkathery (talk | contribs)
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Fasciolosis}}
{{Fasciolosis}}
{{cmg}}


{{PleaseHelp}}
==Overview==
'''Fasciolosis''' is an important [[helminth]] disease caused by two [[trematode]]s ''[[Fasciola hepatica]]'' (the common [[Liver Fluke|liver fluke]]) and ''[[Fasciola gigantica]]''. This disease belongs to the plant-borne trematode [[zoonosis|zoonoses]]. In [[Europe]], the [[Americas]] and [[Oceania]] only ''F. hepatica'' is a concern, but the distributions of both species overlap in many areas of [[Africa]] and [[Asia]].<ref name=Mas-Coma05>Mas-Coma, S., Bargues, M.D., Valero, M.A., 2005. Fascioliasis and other plant-borne trematode zoonose. Int. J. Parasitol. 35, 1255–1278.</ref>
 
The definitive host range is very broad and includes many [[Herbivory|herbivorous]] [[mammal]]s, including humans. The [[Biological life cycle|life cycle]] includes freshwater [[snail]]s as an [[intermediate host]] of the parasite.<ref name=Torges99>Torgerson, P., Claxton, J., 1999. Epidemiology and control. In: Dalton, J.P. (Ed.), Fasciolosis. CAB International Publishing, Wallingford, pp. 113–149.</ref> Recently, worldwide losses in animal productivity due to fasciolosis were conservatively estimated at over US$3.2 billion per annum.<ref name=spithill99>Spithill, T.W., Smooker, P.M., Copeman, D.B. 1999. ''Fasciola gigantica'': epidemiology, control, immunology and molecular biology. In: Dalton, J.P. (Ed.), Fasciolosis. CAB International Publishing, Wallingford, pp. 465–525.</ref> In addition, fasciolosis is now recognized as an emerging human disease: the [[World Health Organization]] (WHO) has estimated that 2.4 million people are infected with ''Fasciola'', and a further 180 million are at risk of infection.<ref>Anonymus 1995. Control of Foodborne Trematode Infections. WHO Technical Series No. 849. WHO, Geneva, 157 pp.</ref>[[Image:Fasciola hepatica.JPG|right|thumb|300px|''Fasciola hepatica'']]


==References==
==References==

Latest revision as of 14:44, 7 August 2015

Fasciolosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fasciolosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

Endoscopy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fasciolosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fasciolosis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fasciolosis overview

CDC on Fasciolosis overview

Fasciolosis overview in the news

Blogs on Fasciolosis overview

Directions to Hospitals Treating Fasciolosis

Risk calculators and risk factors for Fasciolosis overview

Template:Cmg

Overview

Fasciolosis is an important helminth disease caused by two trematodes Fasciola hepatica (the common liver fluke) and Fasciola gigantica. This disease belongs to the plant-borne trematode zoonoses. In Europe, the Americas and Oceania only F. hepatica is a concern, but the distributions of both species overlap in many areas of Africa and Asia.[1]

The definitive host range is very broad and includes many herbivorous mammals, including humans. The life cycle includes freshwater snails as an intermediate host of the parasite.[2] Recently, worldwide losses in animal productivity due to fasciolosis were conservatively estimated at over US$3.2 billion per annum.[3] In addition, fasciolosis is now recognized as an emerging human disease: the World Health Organization (WHO) has estimated that 2.4 million people are infected with Fasciola, and a further 180 million are at risk of infection.[4]

File:Fasciola hepatica.JPG
Fasciola hepatica

References

  1. Mas-Coma, S., Bargues, M.D., Valero, M.A., 2005. Fascioliasis and other plant-borne trematode zoonose. Int. J. Parasitol. 35, 1255–1278.
  2. Torgerson, P., Claxton, J., 1999. Epidemiology and control. In: Dalton, J.P. (Ed.), Fasciolosis. CAB International Publishing, Wallingford, pp. 113–149.
  3. Spithill, T.W., Smooker, P.M., Copeman, D.B. 1999. Fasciola gigantica: epidemiology, control, immunology and molecular biology. In: Dalton, J.P. (Ed.), Fasciolosis. CAB International Publishing, Wallingford, pp. 465–525.
  4. Anonymus 1995. Control of Foodborne Trematode Infections. WHO Technical Series No. 849. WHO, Geneva, 157 pp.